Filing Flows › Relay Therapeutics (RLAY) › How it makes money
How Relay Therapeutics (RLAY) makes money
Relay Therapeutics (RLAY) made $350K of revenue in the second quarter 2026 (Q2 2026), -48% from a year earlier.
Drawing the Sankey…
Where each dollar of revenue goes
| Line | Q2 2026 | % of revenue |
|---|---|---|
| Revenue | $350K | 100.0% |
Revenue, quarter by quarter
| Quarter | Revenue | Y/Y |
|---|---|---|
| Q2 2026 | $350K | -48% |
| Q1 2026 | $3.0M | -61% |
| Q4 2025 | $7.0M | — |
| Q2 2025 | $677K | — |
| Q1 2025 | $7.7M | -23% |
From Relay Therapeutics' 10-Q filed Aug 6, 2026 (on EDGAR).
Questions
How does Relay Therapeutics make money?
Relay Therapeutics (RLAY) made $350K of revenue in the second quarter 2026 (Q2 2026), -48% from a year earlier.
Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.